LONDON (Alliance News) - Biopharmaceutical company Oxford BioMedica PLC said Wednesday that it had repaid the full amount drawn down from its GBP5 million loan facility agreement with its largest shareholder following its recent equity fund-raising. Oxford said Monday it had raised GBP21.6 Read More

DIRECTOR DEALINGS: Oxford Biomedica Directors Buy Open-Offer Shares

16th Jun 2014 13:00

LONDON (Alliance News) - Biopharmaceutical company Oxford Biomedica PLC Monday said a group of directors including Chairman Nick Rodgers  purchased a total of 136.2 million shares among them as part of the biopharmaceutical company's recent fund raising.  Non-Executive Director Marti Read More

Oxford BioMedica Misses Fundraising Target As Open Offer Falls Short

16th Jun 2014 09:45

LONDON (Alliance News) - Oxford BioMedica PLC said Monday that it had raised GBP21.6 million through a firm fund-raising and under-subscribed open offer, falling short of its targeted GBP25.7 million. The biopharmaceutical company placed 1.0 billion shares at 2 pence in the firm placing, ra Read More

UK MORNING BRIEFING: Shares Open Lower Ahead Of European CPI

3rd Jun 2014 07:25

LONDON (Alliance News) - UK shares have opened marginally lower Tuesday ahead of European data seen as having a possible influence on Thursday's European Central Bank meeting. <strong>Wolseley</strong> leads the FTSE 100 gainers after reporting a strong third quarter. It is up 2.3%. < Read More

6 7 8 9 10 11 121314 15

FTSE 100 Latest

Value8,809.74

Change53.53